Table 1.
Ref.
|
Sample size
|
Overall survival
|
Major complication rate
|
Minor complication rate
|
Mortality rate
|
D'Onofrio et al[28], 2016 | 51 | - | - | - | - |
D'Onofrio et al[29], 2017 | 18 | Median, 185 d (range, 62-398 d) | 0% | 0% | 0% |
Giardino et al[30], 2013 | 168 | 34.0 mo | 3.70% | 17.70% | 1.80% |
Hadjicostas et al[31], 2006 | 4 | 6 mo | 0% | 25% | 0% |
Kallis et al[33], 2015 | 23 | 226 d (range, 140-526 d) | 0% | 4.30% | 0% |
Song et al[37], 2016 | 6 | NR | 0% | 33.30% | 0% |
Spiliotis et al[38], 2007 | 25 | 33 mo | 0% | - | 0% |
Varshney et al[39], 2006 | 3 | - | 0% | 66.70% | 0% |
Zou et al[41], 2010 | 32 | 17.5 mo | 3.10% | 0% | 0% |
Giardino et al[44], 2017 | 10 | NR | 30% | 0% | 0% |
D’Onofrio et al[46], 2020 | 35 | 310 (65–718) d | 0% | 0% | 0% |
Wang et al[48], 2020 | 11 | 12 mo | 0% | 0% | 0% |
He et al[50], 2020 | 18 | 1-yr 40.5%; 2-yr 27.0% | 22.20% | 50% | 0% |
Fegrachi et al[52], 2019 | 17 | 9 mo (range, 5-11 mo) | 6% | 24% | 0% |
NR: Not reported.